| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 09/04/2007 | US7265133 Biphenylylaminocarbonyl-amino- or -oxypiperidine derivatives, e.g., biphenyl-2-ylcarbamic acid 1-[2-({4-[(4-hydroxybenzylamino)methyl]benzoyl}methylamino)ethyl]piperidin-4-yl ester; treating bronchodilation and COPD |
| 09/04/2007 | US7265132 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases |
| 09/04/2007 | US7265130 anti-obestic activity; Neuropeptide Y antagonist |
| 09/04/2007 | US7265121 Chemical compounds |
| 09/04/2007 | CA2258044C Muscarinic antagonists |
| 09/04/2007 | CA2239174C Novel compounds with analgesic effect |
| 09/04/2007 | CA2181033C Use of n-alkyl derivatives of 1,5-dideoxy-1,5-imino-d-glucitol for the treatment of hepatitis b virus infections |
| 08/30/2007 | WO2007098504A1 Prodrugs of curcumin analogs |
| 08/30/2007 | WO2007096724A1 An improved process for the preparation of amlodipine besylate |
| 08/30/2007 | WO2007096251A1 Inhibitors of cpt in the central nervous system as antidiabetic and/or anti-obesity drugs |
| 08/30/2007 | WO2007096186A1 Substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators |
| 08/30/2007 | WO2007031865A3 Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof |
| 08/30/2007 | US20070203205 treatment and/or prevention of adverse conditions of the central nervous system, including sleep disorders such as insomnia, psychotic disorders such as schizophrenia and psychiatric disorders such as anxiety; example (1S)-1-[2-({4-[(E)-2-(4-fluorophenyl)vinyl]phenyl}sulfonyl)phenyl]ethanol |
| 08/30/2007 | US20070203183 Diaryl piperidines as CB1 modulators |
| 08/30/2007 | US20070203139 Aryl Glycinamide Derivatives And Their Use As Nk1 Antagonists And Serotonin Reuptake Inhibitors |
| 08/30/2007 | US20070203111 Cycloalkylamines as monoamine reuptake inhibitors |
| 08/30/2007 | US20070202600 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 08/30/2007 | US20070202598 New transfection reagents |
| 08/29/2007 | EP1826201A1 Substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators |
| 08/29/2007 | EP1824957A2 Use of atazanavir for improving the pharmacokinetics of drugs metabolized by ugt1a1 |
| 08/29/2007 | EP1824824A1 Intermediates for the preparation of lercanidipine |
| 08/29/2007 | EP1824823A1 Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues |
| 08/29/2007 | EP1824822A2 Novel 4-aminopiperidine derivatives as plasmepsin ii inhibitors |
| 08/29/2007 | EP1824483A2 Muscarinic acetylcholine receptor antagonists |
| 08/29/2007 | CN100334092C Process for producing cyclic thioether and synthetic intermediate thereof |
| 08/29/2007 | CN100334083C Piperidine derivatives as CCR5 inhibitors |
| 08/28/2007 | US7262252 Heat resistance, noncracking; near infrared transparency, maintaining orientation; waveguides; simple steps |
| 08/28/2007 | US7262211 Activity as non-covalent inhibitors of urokinase and having activity in reducing or inhibiting blood vessel formation are provided. These compounds have at a group having a guanidino moiety or derivative thereof. These compounds are useful for |
| 08/28/2007 | US7262208 Hydroxypropyl amides for the treatment of Alzheimer's disease |
| 08/28/2007 | US7262205 Biphenyl compounds useful as muscarinic receptor antagonists |
| 08/28/2007 | US7262198 Substituted heterocyclic compounds |
| 08/23/2007 | WO2007093603A1 1-phenethylpiperidine derivatives and their use as opioid receptor ligands |
| 08/23/2007 | WO2007057226A3 Process for making donepezil |
| 08/23/2007 | US20070197798 Process for producing cyclic n-hydroxy imide compounds |
| 08/23/2007 | US20070197601 Use of N-[Phenyl(piperidin-2-yl)methyl]benzamide derivatives in therapy |
| 08/23/2007 | US20070197597 Process for the preparation of tryptase inhibitors |
| 08/23/2007 | US20070197594 Cyclic amine derivative or salt thereof |
| 08/23/2007 | US20070197589 Cyclic quaternary amino derivatives as modulators of chemokine receptors |
| 08/23/2007 | US20070197533 Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds |
| 08/23/2007 | CA2641913A1 1-phenethylpiperidine derivatives and their use as opioid receptor ligands |
| 08/22/2007 | EP1820795A1 Novel anthranilic acid derivative or salt thereof |
| 08/22/2007 | EP1819679A2 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof |
| 08/22/2007 | EP1819667A1 Sulfonamide compounds as cysteine protease inhibitors |
| 08/22/2007 | EP1819342A1 Quinoline tachykinin receptor antagonists |
| 08/22/2007 | EP1554246B1 Dihydropyridinone derivatives as hne inhibitors |
| 08/22/2007 | EP1453804B1 Ccr-3 receptor antagonists vii |
| 08/22/2007 | EP1150970B1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same |
| 08/22/2007 | CN1332964C Plasma carboxypeptidase B inhibitors |
| 08/22/2007 | CN1332939C Novel compounds inhibiting factor Xa activity |
| 08/22/2007 | CN101020655A Process of extracting 1-deoxy nojirimycin |
| 08/21/2007 | US7259250 C-nitroso compounds and use thereof |
| 08/21/2007 | US7259173 Derivatives of 3-phenyl-n-(2-(4-benzyl)-piperidin-1-yl)-ethyl)-acrylamid with ccr-3-receptor antagonistic activity for use in the treatment of inflammations and allergic conditions |
| 08/21/2007 | US7259158 Naphthaline derivatives as H3 inverse agonists |
| 08/21/2007 | US7259157 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists |
| 08/21/2007 | CA2304965C ((cyclo)alkyl substituted)-gamma-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders |
| 08/16/2007 | WO2007092558A2 Sulfonamide derivatives to treat infection with hepatitis c virus |
| 08/16/2007 | WO2007092435A2 11-beta hsd1 inhibitors |
| 08/16/2007 | WO2007092143A1 Crystalline form of remifentanil hydrochloride |
| 08/16/2007 | WO2007091046A1 Chemical compounds |
| 08/16/2007 | WO2007041365B1 3-cyclyl-2- (4-sulfamo yl-phenyl) -n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes |
| 08/16/2007 | WO2007019397A3 6-membered aryl and heteroaryl derivatives for the treatment of hepatitis c virus |
| 08/16/2007 | WO2006052555A8 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 08/16/2007 | US20070191610 Process for the preparation of donepezil hydrochloride |
| 08/16/2007 | US20070191516 Process for the synthesis of amine ethers |
| 08/16/2007 | US20070191488 Method for the treatment of a ubiquitin conjugating disorder |
| 08/16/2007 | US20070191429 Ppar activators |
| 08/16/2007 | US20070191428 Anhydrous crystalline fexofenadine hydrochloride Form C, crystalline fexofenadine acetate monohydrate Form D, crystalline fexofenadine acetate dihydrate Form E, crystalline fexofenadine free base monohydrate Form F; H1 receptor antagonist; antihistaminic drug; reduction of ketonic form, salt formation |
| 08/16/2007 | US20070191420 Kinase inhibitors |
| 08/16/2007 | US20070191392 Dipeptide nitrile cathespin k inhibitors |
| 08/16/2007 | US20070191390 Substituted heterocyclic compounds |
| 08/16/2007 | US20070191358 Novel piperidine derivative for the treatment of depression |
| 08/16/2007 | US20070191347 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 08/16/2007 | US20070191341 N-Substituted Benzene Sulfonamides |
| 08/16/2007 | US20070191340 Compounds Which Modulate The CB2 Receptor |
| 08/16/2007 | US20070189970 Contrast medium for thrombus formation |
| 08/16/2007 | CA2651987A1 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 08/16/2007 | CA2641609A1 11-beta hsd1 inhibitors |
| 08/16/2007 | CA2641307A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 08/16/2007 | CA2641283A1 Crystalline form of remifentanil hydrochloride |
| 08/16/2007 | CA2640229A1 Sulfonamide derivatives to treat infection with hepatitis c virus |
| 08/16/2007 | CA2635138A1 Piperidine derivatives as cxcr3 receptor antagonists |
| 08/15/2007 | EP1818326A1 Nitrogen-containing heterocyclic compounds and pharmaceutical composition containing the compounds |
| 08/15/2007 | EP1818325A2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 08/15/2007 | EP1817309A1 Acetamide compounds as fungicides |
| 08/15/2007 | EP1817287A1 Aromatic ether derivatives useful as thrombin inhibitors |
| 08/15/2007 | EP1817286A1 Donepezil salts suitable for the preparation of pharmaceutical compositions |
| 08/15/2007 | EP1817285A2 Cycloalkyl keto piperidine tachykinin receptor antagonists |
| 08/15/2007 | EP1817284A2 Cycloalkyl piperidine tachykinin receptor antagonists |
| 08/15/2007 | EP1817033A1 Treatment of inflammatory bowel disease |
| 08/15/2007 | EP1646620B1 Substituted piperidines as histamine h3 receptor ligands |
| 08/15/2007 | EP1569896B1 Tetrahydro-naphthalene derivatives |
| 08/15/2007 | EP1322596B1 Zwitterionic tachykinin receptor antagonists |
| 08/15/2007 | CN1331855C Antifungal compound and its prepn process and application |
| 08/15/2007 | CN1331848C Tricyclic steroid hormone nuclear receptor modulators |
| 08/15/2007 | CN101018777A Process for preparing N-(substituted arylmethyl)-4-substituted-4- (disubstituted methyl) piperidines and intermediates |
| 08/15/2007 | CN101018776A Processes for preparing N-(substituted methyl)-4-(disubstituted methyl)piperidines and intermediates |
| 08/15/2007 | CN101018774A Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 08/15/2007 | CN101018769A Dimeric piperidine derivates |
| 08/14/2007 | US7257287 Optical interleaver |
| 08/14/2007 | US7256295 Process for producing 2,3-diamino-6-methoxypyridine |